These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26103611)

  • 21. The detection of heterozygous familial hypercholesterolemia in Ireland.
    O'Kane MJ; Menown IB; Graham I; Maher V; Tomkin G; Nicholls P; Graham C
    Adv Ther; 2012 May; 29(5):456-63. PubMed ID: 22610724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.
    Datta BN; McDowell IF; Rees A
    Curr Opin Lipidol; 2010 Aug; 21(4):366-71. PubMed ID: 20613514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Heterozygous familial hypercholesterolemia].
    Özcan ÖU; Güleç S
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():10-8. PubMed ID: 25693359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular diagnosis of familial hypercholesterolaemia.
    Graham CA; Latten MJ; Hart PJ
    Curr Opin Lipidol; 2017 Aug; 28(4):313-320. PubMed ID: 28463860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?
    Sarkies M; Jones LK; Pang J; Sullivan D; Watts GF
    Curr Atheroscler Rep; 2023 Apr; 25(4):133-143. PubMed ID: 36806760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia.
    Bhatnagar D; Morgan J; Siddiq S; Mackness MI; Miller JP; Durrington PN
    BMJ; 2000 Dec; 321(7275):1497-500. PubMed ID: 11118175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial hypercholesterolaemia: optimum treatment strategies.
    Ballantyne CM
    Int J Clin Pract Suppl; 2002 Jul; (130):22-6. PubMed ID: 12296605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of cascade testing for the detection of familial hypercholesterolaemia.
    Hadfield SG; Humphries SE
    Curr Opin Lipidol; 2005 Aug; 16(4):428-33. PubMed ID: 15990592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of heterozygous familial hypercholesterolaemia in children.
    Nicholls DP; Cather M; Byrne C; Graham CA; Young IS
    Int J Clin Pract; 2008 Jul; 62(7):990-4. PubMed ID: 18492057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Robinson JG
    J Manag Care Pharm; 2013 Mar; 19(2):139-49. PubMed ID: 23461430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
    Atherosclerosis; 1999 Jan; 142(1):105-12. PubMed ID: 9920511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.
    ; Vallejo-Vaz AJ; Akram A; Kondapally Seshasai SR; Cole D; Watts GF; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Freiberger T; Abifadel M; Aguilar-Salinas CA; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Ceska R; Corral P; Descamps O; Dieplinger H; Do CT; Durst R; Ezhov MV; Fras Z; Gaita D; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Lin J; Lin N; Maher V; Majano N; Marais AD; März W; Mirrakhimov E; Miserez AR; Mitchenko O; Nawawi H; Nilsson L; Nordestgaard BG; Paragh G; Petrulioniene Z; Pojskic B; Reiner Ž; Sahebkar A; Santos LE; Schunkert H; Shehab A; Slimane MN; Stoll M; Su TC; Susekov A; Tilney M; Tomlinson B; Tselepis AD; Vohnout B; Widén E; Yamashita S; Catapano AL; Ray KK
    Atheroscler Suppl; 2016 Dec; 22():1-32. PubMed ID: 27939304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early initiation of statin treatment in children with familial hypercholesterolaemia.
    Braamskamp MJ; Hutten BA; Wiegman A
    Curr Opin Lipidol; 2015 Jun; 26(3):236-9. PubMed ID: 25943840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
    Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ;
    Eur J Prev Cardiol; 2015 Jul; 22(7):849-54. PubMed ID: 24776375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].
    Sinan ÜY; Sansoy V
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():1-9. PubMed ID: 25693358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing homozygous familial hypercholesterolaemia from cradle to grave.
    Thompson GR
    Atheroscler Suppl; 2015 May; 18():16-20. PubMed ID: 25936299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial hypercholesterolaemia: clinical features and management.
    Pottle A
    Nurs Stand; 2005 Dec 14-2006 Jan 3; 20(14-16):55-65; quiz 66. PubMed ID: 16372559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.
    Santos RD; Gidding SS; Hegele RA; Cuchel MA; Barter PJ; Watts GF; Baum SJ; Catapano AL; Chapman MJ; Defesche JC; Folco E; Freiberger T; Genest J; Hovingh GK; Harada-Shiba M; Humphries SE; Jackson AS; Mata P; Moriarty PM; Raal FJ; Al-Rasadi K; Ray KK; Reiner Z; Sijbrands EJ; Yamashita S;
    Lancet Diabetes Endocrinol; 2016 Oct; 4(10):850-61. PubMed ID: 27246162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial hypercholesterolaemia: A global call to arms.
    Vallejo-Vaz AJ; Kondapally Seshasai SR; Cole D; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Akram A; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Corral P; Descamps O; Dieplinger H; Durst R; Freiberger T; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Nilsson L; Nordestgaard BG; O'Donoghue JM; Sahebkar A; Schunkert H; Shehab A; Stoll M; Su TC; Susekov A; Widén E; Catapano AL; Ray KK
    Atherosclerosis; 2015 Nov; 243(1):257-9. PubMed ID: 26408930
    [No Abstract]   [Full Text] [Related]  

  • 40. Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project.
    Hadfield SG; Horara S; Starr BJ; Yazdgerdi S; Bhatnagar D; Cramb R; Egan S; Everdell R; Ferns G; Jones A; Marenah CB; Marples J; Prinsloo P; Sneyd A; Stewart MF; Sandle L; Wang T; Watson MS; Humphries SE
    Ann Clin Biochem; 2008 Mar; 45(Pt 2):199-205. PubMed ID: 18325186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.